Home

 

 

In This Section

AIPPI World Congress

September 10 to 13, 2022

Location

San Francisco Marriott Marquis
780 Mission Street

San Francisco, California, USA

Contact

Credits

CLE available, total minutes TBD

Registration

Fee: varies

Register Now

AIPPI, hosted by the US Group of AIPPI, will be coming together in person again to take part in the making of AIPPI's resolutions. Experts from different countries and regions will be sharing and exchanging insights on various areas of IP. AIPPI 2022 Congress

Exceptional Programme:

  • Panel Sessions (incl. Pharma Panels)
  • UPC Boot Camp NEW
  • AIPPI Cafés 
  • Women in AIPPI Social Event 
  • Young Members Forum
  • 3 Social Events (incl. Closing Dinner)
    IP Lunches (incl. Diversity and Inclusion Today, Would you like some IP with your Wine?, and Copyright in Graffiti and Street Art)

AIPPI offers an Exclusive Limited Package that includes hotel accommodation at an attractive fee. 

The package is limited and will be offered on a first-come-first-served basis.

For more information, to view the Study Questions, and to learn about Sponsorship Opportunities:  CLICK HERE

CLE will be offered, total amount to be determined. 

If you're not currently a member of AIPPI, you can join and register directly through the registration process.  If you're already an AIPLA member, but are not a member of AIPPI-US, you can join the group during the renewal process by adding AIPPI-US when you renew.  If you're not an AIPLA member, you can join AIPLA and add AIPPI-US through the join process.  For more information about membership eligibility please see the Committee webpage here:  https://www.aipla.org/committees/aippi-us

 

Add to:

 

 

News

  • Washington DC web AIPLA Comments on the OECD's Working Party on Countering Illicit Trade (WP-CIT) Draft Voluntary Guidelines

    August 27, 2025

    Arlington, VA. August 25, 2025 – The American Intellectual Property Law Association (AIPLA) submitted comments to the USPTO on the OECD’s Draft Voluntary Guidelines for Countering Illicit Trade in Counterfeit Goods on Online Marketplaces, highlighting best practices for governments, online marketplace operators, and rights holders.
  • Legislation (1) web Letter of Support - S. 2667 / H.R. 4930 - Customs Info Sharing Authority

    August 13, 2025

    Arlington, VA. August 13, 2025-The American Intellectual Property Law Association (AIPLA) submitted a joint letter with a coalition of organizations representing thousands of American businesses, including many leading global brands, to Senators Grassley, Hassan, and Representatives Moore, and Schneider expressing strong support for S. 2677 / H.R. 4930. The letter highlights the growing threat of counterfeit and pirated goods entering U.S. borders, urges enhanced cooperation between public and private sectors, and commends the legislation for clarifying U.S. Customs and Border Protection’s authority to share information and expand collaboration with key stakeholders to improve intellectual property enforcement.
  • TermDisc-Comments-March21-logo AIPLA Comments on the UPC Mediation and Arbitration Centre’s Draft Mediation Rules

    July 22, 2025

    Arlington, VA. July 21, 2025 – The American Intellectual Property Law Association (AIPLA) submitted comments to the UPC Mediation and Arbitration Centre (PMAC) regarding its proposed Mediation Rules.
  • Senate web AIPLA Submits Letter to US Senate Judiciary Committee on Squires Nomination to the USPTO

    June 16, 2025

    Arlington, VA. June 11, 2025 –The American Intellectual Property Law Association (AIPLA) submitted a letter in response to the nomination of John A. Squires as Director of the United States Patent & Trademark Office (“USPTO”). In view of his impressive background, AIPLA believes Mr. Squires is fully capable of undertaking this important role and appreciates the Senate Judiciary Committee giving this nominee prompt consideration.
  • TermDisc-Comments-March21-logo AIPLA Comments on Draft NMPA Measures

    June 9, 2025

    Arlington, VA. May 17, 2025 –The American Intellectual Property Law Association (AIPLA) submitted comments in response to the National Medical Products Administration’s (NMPA) draft measures on the protection of drug trial data in China.